The FDA currently approves the use of semaglutide and high-dose liraglutide to help treat obesity. This is because these GLP-1 agonists have weight loss effects. Obesity is a chronic condition in which you have a body mass index (BMI) of 30 or higher.
Healthcare providers may also prescribe semaglutide or high-dose liraglutide for people who have overweight along with other health conditions if losing weight can help manage the coexisting conditions. Overweight is when you have a BMI of 25 to 29.9.
Obesity is a complex condition. Effective management often requires several therapies, like:
Dietary changes.
Exercise.
Medications.
Behavior modification programs.
Bariatric (weight loss) surgery.
If you have obesity or overweight, talk to your healthcare provider to see if a GLP-1 agonist is right for you.
